Whitsundays (Nasal) Mask Take Home Study (90 Days)

Sponsor
ResMed (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06036329
Collaborator
(none)
120
2
2
6.3
60
9.6

Study Details

Study Description

Brief Summary

The goal of this multi-site, prospective, randomized, double arm study without blinding is to test the usability of the Whitsundays mask system at home by patients with Obstructive Sleep

Apnea. The main questions it aims to answer are:
  • How the Whitsundays masks performs in the home environment

  • What is the subject's first impression of the Whitsundays mask and what is their preference compared to their own mask

  • What is the difference between the subject's objective therapy data when using the Whitsundays mask compared to their own mask

  • Is there wear and tear of the Whitsundays mask and how frequently do the cushions need replacement Participants will be asked to use the Whitsundays mask for 90 days, answer questionnaires about the initial impression of the mask, the performance of the mask, and their preference compared to their own mask. Researchers will compare one group of subjects who will be provided with cushion replacements to another group who will only be provided with cushion replacements upon request to determine the need for cushion replacement, its frequency, and the reasons for cushion replacement during home usage.

Condition or Disease Intervention/Treatment Phase
  • Device: Group A : provided with 1 Whitsundays Nasal mask without a spare mask cushion
  • Device: Group B : provided with 1 Whitsundays Nasal mask with 2 spare mask cushions
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluating the Usability and Performance of a PAP Mask System in the Home Environment
Actual Study Start Date :
May 31, 2023
Anticipated Primary Completion Date :
Nov 17, 2023
Anticipated Study Completion Date :
Dec 8, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A provided with 1 Whitsundays Nasal mask without a spare mask cushion

• Provided with 1 Whitsundays Nasal mask without a spare mask cushion (To be provided as requested)

Device: Group A : provided with 1 Whitsundays Nasal mask without a spare mask cushion
Group A will be provided with 1 Whitsundays Nasal mask without a spare mask cushion (replacement cushions will only be provided when requested)

Experimental: Group B provided with 1 Whitsundays Nasal mask with 2 spare mask cushions

• Provided with 1 Whitsundays Nasal mask with 2 spare mask cushions

Device: Group B : provided with 1 Whitsundays Nasal mask with 2 spare mask cushions
Group B will be provided with 1 Whitsundays Nasal mask with 2 spare mask cushions

Outcome Measures

Primary Outcome Measures

  1. 11 point Likert Scale Questionnaire [90 days]

    • Subjective scores will be collected from subjects on each attribute being assessed (e.g. visual appeal, ease of use, ease of cleaning, seal, comfort, overall performance etc.). Scores will be collected using an 11-point Likert Scale Questionnaire. Minimum value will be zero. Maximum value will be 10. A higher score indicates better outcomes. A score of 10 is considered very favorable, and a score of 0 is very unfavorable.

Secondary Outcome Measures

  1. 11 point Likert Scale Questionnaire [90 days]

    • Subject's subjective impression and comments comparing the prototype mask (Whitsundays Nasal) to the subject's current mask with regards to ease of use, visual appearance, seal, comfort, facial markings, noise and overall performance. • Scores will be collected using an 11-point Likert Scale Questionnaire. Minimum value will be zero. Maximum value will be 10. A higher score indicates better outcomes. A score of 10 is considered very favorable, and a score of 0 is very unfavorable.

  2. Apnea Hypopnea Index (AHI) [90 days]

    • The AHI recorded by the subject's PAP device while using their own mask will be compared to the AHI recorded by the subject's PAP device while using the Whitsundays mask. The AHI will be obtained from the ResMed AirView Compliance Reports downloaded from the subject's PAP device during the study visits.

  3. Compliance [90 days]

    • The subject's average daily hours of use of PAP therapy recorded by the subject's PAP device while using their own mask will be compared to the average daily hours of use recorded by the subject's PAP device while using the Whitsundays mask. The average daily hours of use will be obtained from the ResMed AirView Compliance Reports downloaded from the subject's PAP device during the study visits.

  4. Leak [90 days]

    The median air leak (L/minute) recorded by the subject's PAP device while using their own mask will be compared to the median air leak (L/minute) recorded by the subject's PAP device while using the Whitsundays mask. The median air leak will be obtained from the ResMed AirView Compliance Reports downloaded during the study visits.

  5. Pressure Differences [90 days]

    The median air pressure (cmH2O) used during PAP therapy recorded by the subject's PAP device while using their own mask will be compared to the median air pressure (cmH2O) recorded by the subject's PAP device while using the Whitsundays mask. The median air pressure levels will be obtained from the ResMed AirView Compliance Reports downloaded from the subject's PAP device during the study visits.

  6. Frequency of Cushion Replacement [90 days]

    • Subject's frequency of cushion replacement will be recorded using the Mask Cushion Change Form to be provided to Group B participants on Day 14 and every 2 weeks for the duration of the study. The Mask Cushion Change form will be provided to Group A participants who request a cushion change.

  7. Reason for Cushion Replacement [90 days]

    • Subject's reason for cushion replacement will be recorded using the Mask Cushion Change Form to be provided to Group B participants on Day 14 and every 2 weeks for the duration of the study. The Mask Cushion Change form will be provided to Group A participants who request a cushion change.

  8. Deterioration of Mask [90 days]

    • Photos of the subject's prototype mask system taken at 2-week intervals to observe any visual deterioration such as cracking, crazing, tears, dirt or stain build up

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients willing to give written informed consent

  • Patients who can read and comprehend English

  • Patients who ≥ 18 years of age

  • Patients being treated for OSA with a PAP device for ≥ 6 months

  • Patients currently using a ResMed PAP device (S9, AirSense 10 & AirSense 11) compatible with AirView (with cellular data connectivity and has been sending device data to the cloud)

  • Patients currently using ResMed AirFit N30i or Philips DreamWear™ Nasal

  • Patients who are willing to try the prototype mask for up to 90 nights

  • Patients who are willing to take photos of the prototype mask every 2 weeks for the duration of the study

  • Patients who reside in the USA and intend to stay in the USA for the next 6 months

  • Patients with access to the internet (such as a smartphone or laptop) to complete online surveys

Exclusion Criteria:
  • Patients using Bilevel flow generators

  • Patients who are or may be pregnant

  • Patients with a preexisting lung disease/condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.

  • If you are pregnant or planning to become pregnant

  • Patients believed to be unsuitable for inclusion by the researcher

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sleep Data San Diego California United States 92123
2 Clayton Sleep Institute Saint Louis Missouri United States 63123

Sponsors and Collaborators

  • ResMed

Investigators

  • Principal Investigator: William Hevener, RPSGT, Sleep Data
  • Principal Investigator: Matthew Uhles, MS, Clayton Sleep Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ResMed
ClinicalTrials.gov Identifier:
NCT06036329
Other Study ID Numbers:
  • SLP-23-02-01
  • D638-1118
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023